These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9186149)

  • 1. Mycobacterium szulgai infection of the lung: case report and review of an unusual pathogen.
    Benator DA; Kan V; Gordin FM
    Am J Med Sci; 1997 Jun; 313(6):346-51. PubMed ID: 9186149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of disseminated Mycobacterium szulgai infection with ciprofloxacin, rifampicin, and ethambutol.
    Fang CT; Chang SC; Luh KT; Chang YL; Hsueh PR; Hsieh WC
    J Infect; 1999 May; 38(3):195-7. PubMed ID: 10424803
    [No Abstract]   [Full Text] [Related]  

  • 3. Cavitary lung infection caused by Mycobacterium flavescens.
    Casimir MT; Fainstein V; Papadopolous N
    South Med J; 1982 Feb; 75(2):253-4. PubMed ID: 7058379
    [No Abstract]   [Full Text] [Related]  

  • 4. Mycobacterium szulgai: an unusual pathogen.
    Dylewski JS; Zackon HM; Latour AH; Berry GR
    Rev Infect Dis; 1987; 9(3):578-80. PubMed ID: 3602795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response to chemotherapy of pulmonary infection due to mycobacterium kansasii.
    Harris GD; Johnason WG; Nicholson D
    Bull Int Union Tuberc; 1976; 51(1):275-8. PubMed ID: 1030296
    [No Abstract]   [Full Text] [Related]  

  • 6. The course of untreated Mycobacterium kansasii disease.
    Francis PB; Jay SJ; Johanson WG
    Am Rev Respir Dis; 1975 Apr; 111(4):477-87. PubMed ID: 1124888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifocal osteomyelitis due to Mycobacterium szulgai in a patient with chronic lymphocytic leukemia.
    Meyer JJ; Gelman SS
    J Infect; 2008 Feb; 56(2):151-4. PubMed ID: 18199481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycobacterium kansasii pulmonary infection: a prospective study of the results of nine months of treatment with rifampicin and ethambutol. Research Committee, British Thoracic Society.
    Thorax; 1994 May; 49(5):442-5. PubMed ID: 8016763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemotherapeutic regimens for nontuberculous mycobacterial infection based on in-vitro susceptibility test results].
    Tsukamura M; Yamori S
    Kekkaku; 1990 May; 65(5):349-57. PubMed ID: 2168003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary Mycobacterium szulgai infection in an immunocompetent patient.
    Lin JN; Lai CH; Chen YH; Huang CK; Lin HF; Eng HL; Lin HH
    South Med J; 2009 Sep; 102(9):979-81. PubMed ID: 19668034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disseminated Mycobacterium celatum disease with prolonged pulmonary involvement.
    Patsche CB; Svensson E; Wejse C
    Int J Infect Dis; 2014 Sep; 26():88-90. PubMed ID: 25008771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Two cases of pulmonary infection by Mycobacterium abscessus in which drug susceptibility testing results conflicted with clinical courses].
    Nishizawa Y; Fujimura M; Tagami A; Abo M; Honjyo C; Yasui M; Nakao S
    Nihon Kokyuki Gakkai Zasshi; 2005 Apr; 43(4):241-6. PubMed ID: 15966372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuberculoid tenosynovitis and carpal tunnel syndrome caused by Mycobacterium szulgai.
    Stratton CW; Phelps DB; Reller LB
    Am J Med; 1978 Aug; 65(2):349-51. PubMed ID: 686019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nine-year progression of untreated pulmonary Mycobacterium szulgai infection.
    Randhawa K; Smethurst P; Soo Hoo GW
    South Med J; 2010 Aug; 103(8):828-30. PubMed ID: 20622732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous Mycobacterium thermoresistibile infection in a heart transplant recipient.
    Neeley SP; Denning DW
    Rev Infect Dis; 1989; 11(4):608-11. PubMed ID: 2672240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary infections caused by less frequently encountered slow-growing environmental mycobacteria.
    Hoffner SE
    Eur J Clin Microbiol Infect Dis; 1994 Nov; 13(11):937-41. PubMed ID: 7698120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM; Goldberg SV
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary disease caused by Mycobacterium terrae complex.
    Tonner JA; Hammond MD
    South Med J; 1989 Oct; 82(10):1279-82. PubMed ID: 2678502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycobacterium szulgai; a new pathogen causing infection of the lung.
    Davidson PT
    Chest; 1976 Jun; 69(6):799-801. PubMed ID: 1277906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of clinical efficacy of isoniazid and ethambutol in the treatment of nontuberculous mycobacteriosis based on in vitro susceptibility testing].
    Tsukamura M
    Kekkaku; 1989 Aug; 64(8):511-8. PubMed ID: 2811008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.